Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hayden's Batten Disease Foundation is a non-profit organization dedicated to finding a cure for CLN3 Batten disease, also known as Juvenile Neuronal Ceroid Lipofuscinosis. Established in 2009 following the diagnosis of Hayden Lord, the foundation focuses on raising awareness and funding critical research to accelerate the development of effective treatments. They have played a significant role in supporting clinical trials, including studies involving Miglustat, and advancing gene therapy research at leading academic institutions. By partnering with other advocacy groups and researchers, the foundation aims to provide hope and tangible medical progress for families affected by this rare, fatal neurodegenerative disorder. Their efforts are primarily funded through community events and private donations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hayden's Batten Disease Foundation.